09:26 AM EDT, 05/01/2025 (MT Newswires) -- Madrigal Pharmaceuticals ( MDGL ) reported a Q1 net loss Thursday of $3.32 per diluted share, narrower than a loss of $7.38 a year earlier.

Analysts polled by FactSet expected a loss of $3.75.

Revenue for the quarter ended March 31 was $137.3 million. The company didn't provide a year-earlier figure. Analysts surveyed by FactSet expected $114.7 million.

The company said it had cash, cash equivalents, restricted cash and marketable securities of $848.1 million as of March 31, compared with $931.3 million as of Dec. 31.

The company's shares were up more than 2% in recent premarket activity.